跳至主要内容
临床试验/EUCTR2019-002826-58-NL
EUCTR2019-002826-58-NL进行中(未招募)1 期

The effects of enoximone in acute exacerbation COPD: a pilot study

Rijnstate Hospital, Arnhem0 个研究点目标入组 15 人开始时间: 2020年2月5日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with an AE-COPD wherefore intubation occurred within 24 hours before enrollment.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 5

排除标准

  • Patients with known asthma or interstitial lung disease (ILD)
  • Known neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Guillain-Barre and Dementia
  • Hypertrophic obstructive cardiomyopathy (HOCM)
  • Severe aortic stenosis with aortic valve area < 1cm2
  • Known ventricular arrhythmias
  • Severe kidney disorders with Glomerular Filtration Rate (GFR) < 30
  • Severe liver insufficiency with spontaneous PT/INR > 1.5

研究者

发起方
Rijnstate Hospital, Arnhem

相似试验